NVIDIA has announced collaborations with industry leaders to revolutionize the healthcare and life sciences sectors by leveraging AI and accelerated computing technologies.
IQVIA, a global provider of clinical research services and healthcare intelligence, is utilizing NVIDIA’s AI Foundry service to develop custom foundation models based on its extensive data. This initiative aims to expedite research and clinical development while ensuring adherence to privacy, regulatory compliance, and patient safety standards.
Illumina, renowned for its DNA sequencing technologies, is collaborating with NVIDIA to enhance genomics for drug discovery. By integrating NVIDIA’s AI tools into its multiomics analysis software, Illumina seeks to broaden access to genomic insights for researchers and pharmaceutical companies globally.
Mayo Clinic is accelerating the development of pathology foundation models using NVIDIA’s technology. Their Digital Pathology platform, which includes a vast dataset of whole-slide images and patient records, will benefit from NVIDIA’s DGX systems and healthcare imaging platform MONAI. This partnership focuses on enhancing personalized diagnostics and treatment strategies.
Arc Institute is working with NVIDIA to develop AI models aimed at advancing biomedical discovery. By combining expertise in biology and machine learning, the partnership intends to create scalable foundation models that can generalize across various biological modalities.
These collaborations underscore NVIDIA’s commitment to transforming healthcare through AI, with the potential to significantly improve patient outcomes and accelerate the development of new treatments.
